CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $478.48M | Feb 13, 2018 |
| FY2017 | Sep 30, 2017 | $464.23M | Feb 13, 2018 |
| FY2017 | Jul 1, 2017 | $469.13M | Feb 13, 2018 |
| FY2017 | Apr 1, 2017 | $445.76M | Feb 13, 2018 |
| FY2017 | Dec 31, 2016 | $466.79M | Feb 13, 2018 |
| FY2017 | Sep 24, 2016 | $425.72M | Feb 13, 2018 |
| FY2017 | Jun 25, 2016 | $434.06M | Feb 13, 2018 |
| FY2017 | Mar 26, 2016 | $354.87M | Feb 13, 2018 |
| FY2016 | Dec 26, 2015 | $353.85M | Feb 14, 2017 |
| FY2016 | Sep 26, 2015 | $349.47M | Feb 14, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $4.02B | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $4.05B | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | $4.13B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $3.98B | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $3.54B | Feb 14, 2024 |
| FY2020 | Dec 26, 2020 | $790.99M | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | $743.30M | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | $682.58M | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | $707.06M | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | $691.14M | Feb 17, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $1.86B | Feb 13, 2018 |
| FY2017 | Dec 31, 2016 | $1.68B | Feb 13, 2018 |
| FY2017 | Dec 26, 2015 | $1.36B | Feb 13, 2018 |
| FY2016 | Dec 27, 2014 | $1.30B | Feb 14, 2017 |
| FY2015 | Dec 28, 2013 | $1.17B | Feb 12, 2016 |
| FY2014 | Dec 29, 2012 | $1.13B | Feb 17, 2015 |
| FY2013 | Dec 31, 2011 | $1.14B | Feb 25, 2014 |
| FY2012 | Dec 25, 2010 | $1.13B | Feb 27, 2013 |
| FY2011 | Dec 26, 2009 | $1.17B | Feb 27, 2012 |
| FY2010 | Dec 27, 2008 | $1.30B | Feb 23, 2011 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 26, 2020 | $299.97M | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | $289.27M | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | $232.24M | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | $252.06M | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | $262.31M | Feb 17, 2021 |
| FY2020 | Sep 28, 2019 | $246.12M | Feb 17, 2021 |
| FY2020 | Jun 29, 2019 | $238.10M | Feb 17, 2021 |
| FY2020 | Mar 30, 2019 | $211.78M | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $226.42M | Feb 11, 2020 |
| FY2019 | Sep 29, 2018 | $216.20M | Feb 11, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($144.34M) | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $22.20M | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | $474.62M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $486.23M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $390.98M | Feb 14, 2024 |
| FY2020 | Dec 26, 2020 | $143.19M | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | $102.91M | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | $67.44M | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | $50.77M | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | $80.35M | Feb 17, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $25.16M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $227.35M | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | $617.26M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $650.98M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $589.86M | Feb 14, 2024 |
| FY2020 | Dec 26, 2020 | $128.93M | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | $132.75M | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | $76.77M | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | $94.28M | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | $108.79M | Feb 17, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $743.07M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $751.00M | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | $747.86M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $665.10M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $619.92M | Feb 14, 2024 |
| FY2022 | Dec 26, 2020 | $528.94M | Feb 22, 2023 |
| FY2021 | Dec 28, 2019 | $517.62M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $443.85M | Feb 17, 2021 |
| FY2019 | Dec 30, 2017 | $371.27M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $364.71M | Feb 13, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $737.65M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $734.58M | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | $683.90M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $619.64M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $760.80M | Feb 14, 2024 |
| FY2022 | Dec 26, 2020 | $546.58M | Feb 22, 2023 |
| FY2021 | Dec 28, 2019 | $480.94M | Feb 16, 2022 |
| FY2018 | Dec 29, 2018 | $441.14M | Feb 13, 2019 |
| FY2018 | Dec 30, 2017 | $318.07M | Feb 13, 2019 |
| FY2018 | Dec 31, 2016 | $316.90M | Feb 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $7.14B | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $7.53B | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $8.20B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $7.60B | Feb 14, 2024 |
| FY2022 | Dec 25, 2021 | $7.02B | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | $5.49B | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $4.69B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $3.86B | Feb 11, 2020 |
| FY2018 | Dec 30, 2017 | $2.93B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $2.71B | Feb 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $3.92B | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $4.02B | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $4.54B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $4.58B | Feb 14, 2024 |
| FY2022 | Dec 25, 2021 | $4.43B | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | $3.35B | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $3.03B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $2.52B | Feb 11, 2020 |
| FY2018 | Dec 30, 2017 | $1.87B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $1.86B | Feb 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $3.16B | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $3.46B | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $3.60B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $2.98B | Feb 14, 2024 |
| FY2022 | Dec 25, 2021 | $2.53B | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | $2.11B | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $1.63B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $1.32B | Feb 11, 2020 |
| FY2018 | Dec 30, 2017 | $1.05B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $836.77M | Feb 13, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $2.76B | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $2.85B | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $3.10B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $2.85B | Feb 14, 2024 |
| FY2022 | Dec 25, 2021 | $2.71B | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | $1.81B | Feb 16, 2022 |
| FY2021 | Dec 28, 2019 | $1.54B | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $1.25B | Feb 17, 2021 |
| FY2019 | Dec 30, 2017 | $804.91M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $787.52M | Feb 13, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $1.39B | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $1.81B | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $1.89B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $1.43B | Feb 14, 2024 |
| FY2022 | Dec 25, 2021 | $980.75M | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | $625.41M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $280.33M | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $42.10M | Feb 11, 2020 |
| FY2018 | Dec 30, 2017 | $288.66M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $165.30M | Feb 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $213.77M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $194.61M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $276.77M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $233.91M | Feb 14, 2024 |
| FY2022 | Dec 25, 2021 | $241.21M | Feb 22, 2023 |
| FY2022 | Dec 26, 2020 | $228.42M | Feb 22, 2023 |
| FY2021 | Dec 28, 2019 | $238.01M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $195.44M | Feb 17, 2021 |
| FY2019 | Dec 30, 2017 | $163.79M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $117.63M | Feb 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 29, 2018 | $1.61B | Feb 13, 2019 |
| FY2018 | Dec 30, 2017 | $1.09B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $1.18B | Feb 13, 2018 |
| FY2016 | Dec 26, 2015 | $814.24M | Feb 14, 2017 |
| FY2015 | Dec 27, 2014 | $716.64M | Feb 12, 2016 |
| FY2014 | Dec 28, 2013 | $663.05M | Feb 17, 2015 |
| FY2013 | Dec 29, 2012 | $666.45M | Feb 25, 2014 |
| FY2012 | Dec 31, 2011 | $717.90M | Feb 27, 2013 |
| FY2011 | Dec 25, 2010 | $700.75M | Feb 27, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | (2) | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | 9 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 9 | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | 7 | Feb 14, 2024 |
| FY2020 | Dec 26, 2020 | 2 | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | 2 | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | 1 | Feb 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | (2) | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | 9 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 9 | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | 7 | Feb 14, 2024 |
| FY2020 | Dec 26, 2020 | 2 | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | 2 | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | 1 | Feb 17, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 49.22M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | 51.14M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | 51.34M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 50.94M | Feb 14, 2024 |
| FY2022 | Dec 25, 2021 | 50.48M | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | 49.77M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | 48.94M | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | 48.21M | Feb 11, 2020 |
| FY2018 | Dec 30, 2017 | 47.40M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | 47.36M | Feb 13, 2018 |